Development of a Low-cost NGS Test for the Evaluation of Thyroid Nodules
Autor: | Divya Vishwanath, Urvashi Bahadur, Ashwini Shanmugam, Akhila Lakhsmikantha, Vijay Pillai, Pobbisetty Radhakrishnagupta Rekha, Kranti Khadilkar, Vidhya Bushan, Amritha Suresh, Mahima Sundaresh, Arun K Hariharan, Subramanian Kannan, K. S. Shivaprasad, Narayana Subramaniam, Moni Abraham Kuriakose, Vamsi Veeramachaneni, Sum Sum, Shradha Saraf, Vivek Shetty, Shaesta Naseem Zaidi, Vaijayanti Gupta, Naveen Hedne Chandrasekhar |
---|---|
Rok vydání: | 2019 |
Předmět: |
Thyroid nodules
medicine.medical_specialty business.industry Thyroid Malignancy medicine.disease 03 medical and health sciences 0302 clinical medicine medicine.anatomical_structure Oncology Surgical oncology 030220 oncology & carcinogenesis medicine Original Article 030211 gastroenterology & hepatology Surgery Histopathology Radiology Indeterminate business Fine-needle aspirate Thyroid cancer |
Zdroj: | Indian J Surg Oncol |
ISSN: | 0976-6952 0975-7651 |
Popis: | Ultrasound-guided fine needle aspiration cytology (FNAC) is the preferred method of identifying malignancy in palpable thyroid nodules using the Bethesda reporting system. However, in around 30–40% of FNACs (Bethesda categories III, IV, and V), the results are indeterminate and surgery is required to confirm malignancy. Out of those who undergo surgery, only 10–40% of patients in these categories are found to have malignancies, thus proving surgery to be unnecessary for some patients or to be incomplete in others. While molecular testing on thyroid FNAC material is part of the American Thyroid Association (ATA) guidelines in evaluating thyroid nodules, it is currently unavailable in India due to cost constraints. In this study, we prospectively collected FNAC samples from sixty-nine patients who presented with palpable thyroid nodules. We designed a cost-effective next-generation sequencing (NGS) test to query multiple variants in the DNA and RNA isolated from the fine needle aspirate. The identification of oncogenic variants was considered to be indicative of malignancy, and confirmed by surgical histopathology. The panel showed an overall sensitivity of 81.25% and a specificity of 100%, while in the case of Bethesda categories III, IV, and V, the sensitivity was higher (87.5%) and the specificity was established at 100%. The panel could thereby serve as a rule-in test for the diagnosis of thyroid cancer and therefore help identify patients who require surgery, especially in the indeterminate Bethesda categories III, IV, and V. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s13193-019-01000-w) contains supplementary material, which is available to authorized users. |
Databáze: | OpenAIRE |
Externí odkaz: |